Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Just - Evotec Biologics
company
About
Designing innovative technologies focused on accelerating global access to biotherapeutics.
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $14M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2014
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Just Evotec Biologics was founded in 2014 and acquired by Evotec in 2019. The company has an intense focus on the design of innovative and integrated technologies to accelerate the development of biotherapeutics and reduce their manufacturing cost. Core strengths include antibody discovery, molecular design, process and product design and manufacturing plant design.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$29M
Just - Evotec Biologics has raised a total of
$29M
in funding over 2 rounds. Their latest funding was raised on
Jul 25, 2016 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 25, 2016 | Series A | $14M | 3 | — | — | Detail |
| Sep 21, 2015 | Series A | $15M | 3 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Just - Evotec Biologics has made 1 investments. Their most recent investment was on
Nov 2, 2021, when Upland raised $18M.
Investors
Number of Lead Investors
Number of Investors
—
3
Just - Evotec Biologics is funded by 3 investors.
Merck
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Merck
|
— | Series A |
ARCH Venture Partners
|
— | Series A |
Lilly Asia Ventures
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
